Morphomolecular Characterization of Neoplastic and Pre-neoplastic Lesions in Solid Malignancies

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 277

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA
Interests: breast cancer; urogenital cancers; neuropathology; molecular pathology; digital pathology; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy
Interests: hormone-sensitive prostate cancer; metastatic castration-resistant prostate cancer; androgen receptor agents; bone health agents; bone metastases; cfDNA; taxanes; biomarkers
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA
Interests: genitourinary malignancies; liquid biopsy; cfDNA; methylated DNA; genetic and epigenetic biomarkers
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy
2. Department of Laboratory Medicine, Pisa University Hospital, 56126 Pisa, Italy
Interests: pathology; tumour microenvironment; molecular genetics; breast cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Traditionally, morphological evaluation represented the conventional approach for diagnosing and classifying neoplastic and pre-neoplastic lesions. However, recent advancements in molecular biology techniques have deeply revolutionized our understanding of solid malignancies contributing to the investigation of genetic alterations, gene expression patterns, epigenetic modifications, and protein expression that drive tumor initiation, progression, and metastasis. This knowledge has opened up opportunities for the development of targeted therapies that specifically inhibit these pathways. Moreover, molecular profiling integrated with morphological analysis can significantly improve diagnostic accuracy, prognostic stratification, and tailored treatment strategies, leading to improved therapeutic outcomes and minimizing adverse effects.

In conclusion, the morphomolecular characterization of neoplastic and pre-neoplastic lesions in solid malignancies represents a multidisciplinary approach that combines traditional morphological analysis with cutting-edge molecular techniques. This integrated approach provides a comprehensive understanding of the complex landscape of tumors and holds great promise for improving diagnosis, prognosis, and treatment outcomes in the field of oncology. Continued research in this area will undoubtedly lead to further advancements and breakthroughs in our fight against cancer.

We especially welcome original translational research studies highlighting new findings in the abovementioned areas, and short communications of preliminary but significant experimental results. In addition, experts in the field will review the current diagnostic, therapeutic, and experimental models.

Dr. Giuseppe Nicolò Fanelli
Dr. Edoardo Francini
Dr. Pier Vitale Nuzzo
Dr. Cristian Scatena
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • solid cancer
  • molecular pathology
  • histopathology
  • diagnostic, prognostic, and predictive biomarkers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop